Literature DB >> 29325047

Early nucleus basalis of Meynert degeneration predicts cognitive decline in Parkinson's disease.

James P Gratwicke1,2, Thomas Foltynie1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29325047      PMCID： PMC5837653          DOI： 10.1093/brain/awx333

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  10 in total

1.  Volumetric analysis of the substantia innominata in patients with Parkinson's disease according to cognitive status.

Authors:  Seo Hee Choi; Tae Min Jung; Ji E Lee; Seung-Koo Lee; Young H Sohn; Phil Hyu Lee
Journal:  Neurobiol Aging       Date:  2011-01-08       Impact factor: 4.673

Review 2.  The spectrum of cognitive impairment in Lewy body diseases.

Authors:  Jennifer G Goldman; Caroline Williams-Gray; Roger A Barker; John E Duda; James E Galvin
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

3.  Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait.

Authors:  Brett W Fling; Rajal G Cohen; Martina Mancini; John G Nutt; Damian A Fair; Fay B Horak
Journal:  Brain       Date:  2013-07-03       Impact factor: 13.501

4.  Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease.

Authors:  Michel Grothe; Laszlo Zaborszky; Mercedes Atienza; Eulogio Gil-Neciga; Rafael Rodriguez-Romero; Stefan J Teipel; Katrin Amunts; Aida Suarez-Gonzalez; Jose L Cantero
Journal:  Cereb Cortex       Date:  2009-11-04       Impact factor: 5.357

5.  Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.

Authors:  J M Candy; R H Perry; E K Perry; D Irving; G Blessed; A F Fairbairn; B E Tomlinson
Journal:  J Neurol Sci       Date:  1983-05       Impact factor: 3.181

6.  The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.

Authors:  Caroline H Williams-Gray; Jonathan R Evans; An Goris; Thomas Foltynie; Maria Ban; Trevor W Robbins; Carol Brayne; Bhaskar S Kolachana; Daniel R Weinberger; Stephen J Sawcer; Roger A Barker
Journal:  Brain       Date:  2009-10-07       Impact factor: 13.501

Review 7.  The nucleus basalis of Meynert: a new target for deep brain stimulation in dementia?

Authors:  James Gratwicke; Joshua Kahan; Ludvic Zrinzo; Marwan Hariz; Patricia Limousin; Thomas Foltynie; Marjan Jahanshahi
Journal:  Neurosci Biobehav Rev       Date:  2013-09-11       Impact factor: 8.989

8.  Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.

Authors:  Anette Schrag; Uzma Faisal Siddiqui; Zacharias Anastasiou; Daniel Weintraub; Jonathan M Schott
Journal:  Lancet Neurol       Date:  2016-11-18       Impact factor: 44.182

Review 9.  Parkinson's disease dementia: a neural networks perspective.

Authors:  James Gratwicke; Marjan Jahanshahi; Thomas Foltynie
Journal:  Brain       Date:  2015-04-16       Impact factor: 13.501

10.  In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.

Authors:  Nicola J Ray; Steven Bradburn; Christopher Murgatroyd; Umar Toseeb; Pablo Mir; George K Kountouriotis; Stefan J Teipel; Michel J Grothe
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501
  10 in total
  1 in total

1.  Deep Brain Stimulation of the Nucleus Basalis of Meynert for Parkinson's Disease Dementia: A 36 Months Follow Up Study.

Authors:  Davide Cappon; James Gratwicke; Ludvic Zrinzo; Harith Akram; Jonathan Hyam; Marwan Hariz; Patricia Limousin; Thomas Foltynie; Marjan Jahanshahi
Journal:  Mov Disord Clin Pract       Date:  2022-07-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.